Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,382 total articles
Tilray Brands, through its BrewDog division, has introduced a new line of nostalgic-flavored ready-to-drink (RTD) cocktails named Wonderland in the UK, starting with Pear Drop Margarita and Fizzy Toffee Apple Martini. The launch aims to disrupt the RTD market with bold, sweet-shop-inspired flavors tailored for modern consumers, backed by strong in-…
Concorde International Group Ltd., a technology-enabled security solutions provider, announced it has secured multi-year contracts worth over US$10 million to deliver integrated security solutions across industrial zones, business districts, and community precincts in Singapore. The contracts involve deployment of the company's proprietary i-Guardi…
Barrick Mining Corporation announced the election of its board of directors, appointment of auditors, and approval of executive compensation at its 2026 Annual Meeting. The company confirmed strong shareholder support for its governance proposals, reinforcing stable management and oversight as it continues operations across 17 countries.
Bitdeer Technologies Group disclosed its first quarter 2026 unaudited financial results, showing significant revenue growth driven by increased mining capacity and AI cloud business expansion. Despite a net loss of $159.5 million, the company achieved a positive adjusted EBITDA of $14.4 million, signaling operational improvements. Bitdeer also prog…
Tiziana Life Sciences announced initial Phase 2 clinical trial results revealing that intranasal foralumab significantly reduces brain inflammation in patients with Multiple System Atrophy (MSA), as measured by PET imaging. This represents the third neurological condition showing marked inflammation reduction with the therapy, which previously show…
GH Research PLC announced its Q1 2026 financial results along with key clinical updates. The company published positive Phase 2b trial results of its lead depression treatment GH001 in JAMA Psychiatry, demonstrating robust remission rates in treatment-resistant depression (TRD). Enrollment completed in Phase 1 studies for dose selection and deliver…
Chicago Atlantic BDC, a specialty finance company focusing on cannabis and middle-market direct lending, reported record first quarter 2026 financial results. The company achieved net investment income of $10.0 million ($0.44 per share), increased its investment portfolio to $364 million, and declared a quarterly dividend of $0.34 per share. The po…
Climb Bio, Inc., a clinical-stage biotech company, announced it will present new clinical data for its investigational drug budoprutug at the European Hematology Association 2026 Congress. The data includes safety and efficacy results from a Phase 1b/2a trial in patients with primary immune thrombocytopenia, highlighting budoprutug’s potential as a…
Cabaletta Bio presented encouraging clinical and translational data for its autologous CAR T cell therapy rese-cel at the ASGCT 2026 Annual Meeting. The data showed that the lowest dose of preconditioning-free rese-cel produced compelling drug-free responses in half of treated refractory patients with pemphigus vulgaris over six months. Additionall…
Willis Lease Finance Corporation announced the pricing of an upsized public offering of $200 million of 2.50% convertible senior notes due 2031, alongside a concurrent offering of borrowed common stock to facilitate hedging transactions. The net proceeds are intended to temporarily repay amounts outstanding under the Company's revolving credit faci…
Ducommun Incorporated will host an Investor Day on September 17, 2026, to update shareholders on progress under its VISION 2027 strategy and to unveil its new five-year strategic plan, VISION 2032. The company plans to highlight growth, investment, and capital allocation strategies aimed at strengthening the company and enhancing shareholder value.…
Fennec Pharmaceuticals reported a 73% year-over-year increase in Q1 2026 net revenues to $15.1 million driven by increased demand for PEDMARK®, an FDA-approved drug to reduce cisplatin-induced ototoxicity in pediatric cancer patients. The company initiated a new clinical study, expanded its sales force, and secured multiple abstract acceptances for…
KANZHUN LIMITED, known as BOSS Zhipin, continues its aggressive share repurchase program, deploying over RMB183 million in May 2026 alone and RMB1.33 billion year-to-date. The Board increased the total authorized repurchase limit to US$400 million through August 2027 and committed to distributing at least 50% of adjusted net income annually via div…
Red Cat Holdings announced that Kymeta has joined its Red Cat Futures Initiative, with Kymeta's satellite communication technology integrated into Blue Ops Variant 7 uncrewed surface vessels (USVs). This partnership enables reliable, resilient, and multi-orbit satellite connectivity for autonomous maritime operations, enhancing range, coordination,…
AH Realty Trust, a REIT focused on retail and office assets primarily in the Mid-Atlantic and Southeastern U.S., has increased its share repurchase authorization by $50 million to a total of $100 million. The Board of Directors' move reflects strong confidence in the company's long-term strategy and capital allocation, following $27.1 million in re…
Cheetah Net Supply Chain Service Inc. reported an 80.7% revenue decline in Q1 2026 to $92,700 compared to Q1 2025, primarily due to reduced business in its acquired subsidiaries and global trade uncertainties. However, operating losses narrowed by 20.4%, driven by cost-cutting efforts. The company also secured private placement and ATM financing an…
Editas Medicine reported strong preclinical data demonstrating that a single dose of its lead in vivo gene editing candidate, EDIT-401, achieved significant and durable LDL-C reduction in non-human primates, supporting its potential as a one-time treatment for hyperlipidemia. The data showed a rapid, substantial, and sustained effect with a favorab…
Reliance Global Group, Inc. disclosed a 1-for-40 reverse stock split effective May 15, 2026, aimed at restoring compliance with Nasdaq's $1.00 minimum bid price requirement. The split will reduce the number of shares outstanding, adjusting the stock price upwards accordingly. The company's CEO emphasized commitment to the business strategy and opti…
Rogers Communications announced a $22 million investment to upgrade its 5G+ network around Toronto's BMO Field and key city locations to support the FIFA World Cup event. Enhancements include adding network infrastructure equivalent to 16 cell towers, deploying more 5G+ spectrum, and installing temporary cellular sites to ensure fast, reliable conn…
LanzaTech Global, Inc. reported its Q1 2026 financial results, highlighting significant improvements including a 59% reduction in operating expenses, a net loss reduction to $14.7 million from $19.2 million year-over-year, and increased revenues to $12 million. The company successfully closed multiple private placements raising $30 million, which a…
Shell plc has released its comprehensive Report on Payments to Governments for 2025, fulfilling disclosure obligations under UK, Dutch, and U.S. regulations. The report details the payments made to governments worldwide from Shell's extractive activities, including production entitlements, taxes, royalties, bonuses, fees, and infrastructure investm…
PDF Solutions, a provider of data solutions for the semiconductor and electronics industries, announced the pricing of an upsized underwritten public offering of 4,568,308 common shares at $44.00 each. The offering includes shares sold by the company and a selling stockholder, with expected gross proceeds to the company of about $55.5 million befor…
Eight Directions Technology Limited, a provider of premium customized disposable products, has entered into a definitive merger agreement with Quartzsea Acquisition Corporation, a Nasdaq-listed special purpose acquisition company (SPAC). The transaction values Eight Directions at approximately $515 million in pre-money equity value and will result …
Propanc Biopharma, a biopharmaceutical company developing novel cancer treatments, has approved a 1-for-25 reverse stock split effective May 18, 2026, aimed at restoring compliance with Nasdaq's $1.00 minimum bid price requirement and supporting its clinical development progress. The reverse split will reduce the number of outstanding shares while …
Bel Fuse Inc., a global manufacturer of electronic components, announced the pricing of an upsized underwritten offering of 1,500,000 Class B common shares at $266.00 per share, raising about $399 million before expenses. The company plans to use proceeds to pay down debt, fund a 20% acquisition stake in Enercon Technologies, and for other acquisit…
